6over6

Smartphone-based Optometric Tools

Health Tech & Life Sciences
Acquired by 1-800 Contacts
Acquired Tel Aviv-Yafo Founded 2014
LinkedIn
Total raised
$15.0M
Last: Series A 2017-11
Stage
Acquired
Founded
2014
Headcount
34
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

6over6 is the developer of GlassesOn, a digital healthcare platform that enables users to perform their own vision test. Its simple-to-use apps are designed to enable a complete and accurate measurement of the refractive error of the eye for prescriptions for eyeglasses or contact lenses. The company's apps are clinically proven to be as accurate as an optometrist's exam. Using only a smartphone, users can accurately measure the refractive error of their eyes through the manipulation of light. GlassesOn users can get a complete prescription for farsighted or nearsighted vision, pupillary distance, and astigmatism. GlassesOn is registered as a Class 1 Exempt Medical Device on the US FDA's Medical Device Listings. However, it does not provide medical advice and does not replace a full eye health exam.

Funding history · 2 rounds · $15.0M total

2017-11
Series A $11.0M
2015-09
Seed $4.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was 6over6 founded and where is its headquarters located?
6over6 was founded in September 2014 and is headquartered in Tel Aviv-Yafo, Israel.
What is the primary product developed by 6over6?
6over6 developed GlassesOn, a digital healthcare platform that allows users to perform vision tests using a smartphone to measure refractive error for eyeglass or contact lens prescriptions.
What was the total funding raised by 6over6 before its acquisition?
6over6 raised a total of $15,000,000 across its funding rounds.
When did 6over6 complete its Seed funding round and who were the investors?
In September 2015, 6over6 completed a Seed funding round with investments from Triventures and Alumot.
When did 6over6 complete its Series A funding round and who was a lead investor?
In November 2017, 6over6 completed its Series A funding round, with Rimonci Capital as a lead investor.
When was 6over6 acquired and by which company?
6over6 was acquired by 1-800 Contacts in December 2019 for $100,000,000.
What was the operational status of 6over6 after its acquisition by 1-800 Contacts?
After being acquired by 1-800 Contacts in December 2019, 6over6 ceased to operate as an independent entity.
What is the current status of the Israeli development center established based on the 6over6 acquisition?
In June 2025, the American company Sequel (which had acquired 6over6) is closing its Israeli development center, resulting in the layoff of approximately 60 employees. The development work will be transferred to a US team.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine LearningComputer Vision
Target customers
Industrial ManufacturingProcess IndustriesGlassHealthcare & Life SciencesHealthcarePatients
Business model
B2CB2B2C

Highlights

1 PatentsVerified

Tags

measurementshome-caremhealthdigital-healthcareophthalmologymobile-applicationsnon-invasivepatientsartificial-intelligencecomputer-visionmachine-learningdiagnosticsoptronicsmedical-technologies